Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study to Evaluate the Cost of the Treatments of the Refractory Psoriatic Arthritis to the Conventional Therapy

NCT00303186 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00303186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00303186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study to Evaluate the Cost of the Treatments of the Refractory Psoriatic Arthritis to the Conventional Therapy
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
February 28, 2005
Completion date
June 30, 2011
Enrollment
107 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, psoriatic, psoriasis